发明名称 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine |
摘要 |
Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful. |
申请公布号 |
US9498452(B2) |
申请公布日期 |
2016.11.22 |
申请号 |
US201514727260 |
申请日期 |
2015.06.01 |
申请人 |
Sunovion Pharmaceuticals Inc. |
发明人 |
Jerussi Thomas;Fang Qun Kevin;Currie Mark G. |
分类号 |
A61K31/135;C07C211/42 |
主分类号 |
A61K31/135 |
代理机构 |
Heslin, Rothenberg, Farley & Mesiti P.C. |
代理人 |
Heslin, Rothenberg, Farley & Mesiti P.C. |
主权项 |
1. A method for treating autism, comprising administering to a patient in need of treatment for autism a therapeutically effective amount of a compound of formula PQ: or a salt thereof. |
地址 |
Marlborough MA US |